What is Leerink Partnrs’ Estimate for AUPH FY2025 Earnings?

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH – Free Report) (TSE:AUP) – Stock analysts at Leerink Partnrs lifted their FY2025 earnings per share (EPS) estimates for shares of Aurinia Pharmaceuticals in a research report issued to clients and investors on Tuesday, November 4th. Leerink Partnrs analyst J. Schwartz now forecasts that the biotechnology company will post earnings of [...]